Signup Crypto ETF Stocks News

7 Information Technology Stocks Whale Activity In Today’s Session

This article details "whale activity" in options trading for seven Information Technology stocks, identifying significant options trades that could indicate unusual market movements. It provides specific data on call and put contracts, expiration dates, strike prices, total trade prices, open interest, and volume for each company, offering insights into potential bullish, bearish, or neutral sentiment. The identified companies include Enphase Energy (ENPH), Applied Materials (AMAT), Qualcomm (QCOM), Atlassian (TEAM), Palantir Technologies (PLTR), Celestica (CLS), and Adobe (ADBE).

Source: Benzinga
June 26, 2026 | 17:35:41
Category: General

Northwest Ohio residents call out Jon Husted for key role in FirstEnergy corruption scandal

Residents and local officials in Toledo protested against U.S. Sen. Jon Husted's alleged role in the HB 6 corruption scandal as FirstEnergy seeks a rate increase that would add approximately $5.30 monthly to residential bills. Demonstrators, including Mayor Wade Kapszukiewicz and State Rep. Erika White, demanded accountability, linking the proposed rate hike to the 2019 HB 6 law which prosecutors called a $60 million corruption scheme. Husted, who was appointed to the U.S. Senate in January 2025 and faces an election, has denied meaningful involvement, stating his interest was in keeping nuclear power plants operational.

Source: TiffinOhio.net
June 26, 2026 | 17:44:45
Category: General

Acadia Pharma Stock Jumps After European Panel Reverses Course On Rett Syndrome Therapy

Acadia Pharmaceuticals (ACAD) stock jumped following a positive recommendation from the European Medicines Agency's CHMP for its drug DAYBU (trofinetide) for treating Rett syndrome. This follows an earlier negative vote, and the recommendation is based on strong Phase 3 LAVENDER study results. Despite the positive news, technical analysis shows the stock is in overbought territory with a recent "death cross" indicating caution for long-term investors.

Source: Benzinga
June 26, 2026 | 17:46:41
Category: General

Deal Dispatch: Penske Buys Vox Media's Digital Brands, AbbVie Acquires Apogee Therapeutics For $10.9 Bill

This "Deal Dispatch" article covers major corporate acquisitions and strategic evaluations. Key announcements include Penske Media Corp.'s purchase of Vox Media's digital brands, AbbVie's $10.9 billion acquisition of Apogee Therapeutics, and Onsemi's $7 billion all-stock agreement to buy Synaptics. Additionally, SPS Commerce and Rayonier Advanced Materials are exploring potential sales, and Camp Mystic filed for Chapter 11 bankruptcy.

Source: Benzinga
June 26, 2026 | 17:53:00
Category: General

American Water Works Co highlights sector trends, shares reflect regulated utility profile

American Water Works Co (AWK) is the largest publicly traded U.S. water and wastewater utility, operating regulated systems across multiple states. The company's earnings and dividend profile is compared to peers like Essential Utilities and California Water Service Group, and its shares exhibit lower earnings volatility but are sensitive to interest rate expectations due to their bond-like equity characteristics. AWK's business model is heavily tilted towards regulated operations, with revenue primarily generated from its rate base, making it a defensive and income-oriented investment within the equity market.

Source: Ad-hoc-news.de
June 26, 2026 | 17:53:10
Category: General

Inside Jefferies’ Latest Call on Lamb Weston Holdings Inc (LW) Stock

Jefferies has reiterated a Buy rating on Lamb Weston Holdings Inc (NYSE:LW) with a $55 price target, despite weakening restaurant foot traffic in the US, expecting solid North American volume growth in fiscal Q4 2026 due to customer wins and an extra sales week. The company, a global supplier of frozen potato products, is also undergoing restructuring in Europe, including closing a production facility in the Netherlands, as part of its "Focus to Win" strategy to improve operational efficiency and market alignment. While acknowledging the potential of LW, the article suggests that some AI stocks may offer higher returns in a shorter timeframe.

Source: Insider Monkey
June 26, 2026 | 17:56:13
Category: General

Vanguard Total World vs iShares MSCI World: Which Global ETF Delivers Better Value

This article compares two global ETFs, Vanguard Total World Stock ETF (VT) and iShares MSCI World ETF (URTH), to determine which offers better value for investors. While VT provides broader diversification across developed and emerging markets at a lower cost, URTH, focusing solely on developed economies, has shown superior long-term performance. The comparison highlights differences in geographic scope, number of holdings, expense ratios, and returns to help investors make an informed decision based on their investment strategy.

Source: The Motley Fool
June 26, 2026 | 18:00:18
Category: General

FS KKR Capital Corp. (FSK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz announces a securities fraud class action lawsuit against FS KKR Capital Corp. (FSK). Investors who suffered losses between May 8, 2024, and February 25, 2026, have until July 6, 2026, to apply to be lead plaintiff. The lawsuit alleges that FS KKR Capital Corp. made materially misleading statements regarding its portfolio restructuring, investment valuations, and distribution strategy.

Source: PR Newswire
June 26, 2026 | 18:04:07
Category: General

Andersons, Inc. Actuals & Estimates (NASDAQ:ANDE)

This article provides an overview of The Andersons, Inc. (NASDAQ: ANDE) stock, including current market price, historical performance, analyst forecasts, and financial data. It highlights the company's recent earnings beat, revenue figures, and dividend information, while also addressing frequently asked questions about investing in ANDE.

Source: TradingView
June 26, 2026 | 18:10:15
Category: General

AbbVie Stock’s Growth Story Has One Question Mark

AbbVie's growth trajectory, following its reliance on Humira, is now primarily driven by Skyrizi and Rinvoq. While Skyrizi shows strong growth, a recent deceleration in Rinvoq's sales growth from 28.6% to 20.2% warrants investor attention. This slowdown could signal increased competitive pressure in the immunology market and challenge the stock's current high valuation, prompting a re-evaluation of its long-term growth prospects.

Source: Trefis
June 26, 2026 | 16:02:58
Category: General

© Natavest 2025 - 2026